Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro

Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro Discovery of Covalent Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase, A Target for the Treatment of Malaria Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds Covalent inhibitors of GAPDH: From unspecific warheads to selective compounds Designing novel inhibitors against falcipain-2 of Plasmodium falciparum Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35 Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity Molecular modeling studies, synthesis and biological evaluation of derivatives of N-phenylbenzamide as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy